Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Cuts Holdings in The Clorox Company (NYSE:CLX)

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group cut its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 24.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,503 shares of the company's stock after selling 2,459 shares during the quarter. Clorox accounts for 0.7% of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group's holdings, making the stock its 27th largest position. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group's holdings in Clorox were worth $1,219,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Avantax Advisory Services Inc. increased its stake in Clorox by 6.3% in the fourth quarter. Avantax Advisory Services Inc. now owns 15,510 shares of the company's stock valued at $2,519,000 after acquiring an additional 920 shares during the last quarter. Essential Planning LLC. bought a new position in Clorox in the fourth quarter valued at approximately $515,000. Great Lakes Advisors LLC bought a new position in Clorox in the fourth quarter valued at approximately $1,306,000. Sequoia Financial Advisors LLC increased its stake in Clorox by 9.4% in the fourth quarter. Sequoia Financial Advisors LLC now owns 4,624 shares of the company's stock valued at $751,000 after acquiring an additional 396 shares during the last quarter. Finally, HighTower Advisors LLC increased its stake in Clorox by 2.8% in the fourth quarter. HighTower Advisors LLC now owns 395,445 shares of the company's stock valued at $64,224,000 after acquiring an additional 10,585 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Remove Ads

Clorox Stock Up 0.3 %

Shares of NYSE:CLX traded up $0.37 during midday trading on Friday, hitting $147.32. 1,035,843 shares of the company's stock were exchanged, compared to its average volume of 1,217,296. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a 50 day moving average price of $154.20 and a 200-day moving average price of $160.20. The company has a market cap of $18.15 billion, a PE ratio of 40.25, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the firm earned $2.16 earnings per share. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.31%. The ex-dividend date is Wednesday, April 23rd. Clorox's payout ratio is presently 133.33%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays raised their target price on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research report on Wednesday, February 5th. JPMorgan Chase & Co. raised their target price on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Finally, DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.